开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2178018, encodeId=b85c21e8018b1, content=请问这个杂志under review就是送外审的意思呢？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri Dec 29 16:43:46 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201991, encodeId=d37e2201991f0, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：提的意见超级无语…水平太差了吧再也不会投这个杂志避雷吧大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d429198215, createdName=ms3000001241002779, createdTime=Mon May 06 12:32:06 CST 2024, time=2024-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2175943, encodeId=986b21e5943a9, content=一直是Awaiting AE First Review的状态不动啊？这是在等什么？外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e039032591, createdName=ms6000000888650478, createdTime=Tue Dec 19 18:16:06 CST 2023, time=2023-12-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1074977, encodeId=838810e497790, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：主编水平确实值得商榷！审稿人建议修改，而且都是小问题，但被主编直接拒绝，给出个可笑的理由---没有创新性！难道这个问题在决定送审前没有评估么？白白浪费几个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f07d2046503, createdName=edsv, createdTime=Mon Nov 29 09:15:09 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186526, encodeId=b01c2186526e8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：AE手里卡了一个月，审稿两个月，两个审稿人给了几句话的没啥建设性的评论，最后以“没有创新性”为理由拒了。编辑部和审稿人效率感觉都不高，这几句话完全要不到这么久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓医生的株式会社, createdTime=Thu Feb 08 14:17:06 CST 2024, time=2024-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2114002, encodeId=2d68211400214, content=审稿速度:2.0 偏重的研究方向：分子免疫;Hepatology;肝病 经验分享：大家好！一审大修under review后状态变成awaiting AE recommendation（等了5天左右），再变成awaiting EIC decision（1天），很快变成awaiting ME final processing（已经3天了），感觉最后一个状态很诡异，大家有类似的经历吗？欢迎沟通交流，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:27:55 CST 2023, time=2023-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125059, encodeId=f55e2125059ae, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=948b8628951, createdName=ms4000000661720880, createdTime=Tue Apr 11 11:52:12 CST 2023, time=2023-04-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116350, encodeId=e1bd21163504a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肝癌 经验分享：请问从接收到online大概要多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b05568141, createdName=ms4000000124404294, createdTime=Fri Feb 24 21:37:10 CST 2023, time=2023-02-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098040, encodeId=1a99209804099, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌 经验分享：6月底投稿，8月初返回大修，3周后重新提交，9月又返回小修，重新提交1个月后最终接收。审稿人意见友好，没有要求稿件的润色证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97be6539292, createdName=ms2000000353363357, createdTime=Wed Nov 02 13:06:31 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114003, encodeId=bcfa2114003dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：awaiting EIC decision后变成awaiting ME final processing是什么意思啊？已经几天了，编辑部处理速度好慢啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:32:58 CST 2023, time=2023-02-10, status=1, ipAttribution=)]

2023-12-29 llllkn 来自浙江省

请问这个杂志under review就是送外审的意思呢？谢谢大家

61 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178018, encodeId=b85c21e8018b1, content=请问这个杂志under review就是送外审的意思呢？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri Dec 29 16:43:46 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201991, encodeId=d37e2201991f0, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：提的意见超级无语…水平太差了吧再也不会投这个杂志避雷吧大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d429198215, createdName=ms3000001241002779, createdTime=Mon May 06 12:32:06 CST 2024, time=2024-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2175943, encodeId=986b21e5943a9, content=一直是Awaiting AE First Review的状态不动啊？这是在等什么？外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e039032591, createdName=ms6000000888650478, createdTime=Tue Dec 19 18:16:06 CST 2023, time=2023-12-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1074977, encodeId=838810e497790, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：主编水平确实值得商榷！审稿人建议修改，而且都是小问题，但被主编直接拒绝，给出个可笑的理由---没有创新性！难道这个问题在决定送审前没有评估么？白白浪费几个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f07d2046503, createdName=edsv, createdTime=Mon Nov 29 09:15:09 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186526, encodeId=b01c2186526e8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：AE手里卡了一个月，审稿两个月，两个审稿人给了几句话的没啥建设性的评论，最后以“没有创新性”为理由拒了。编辑部和审稿人效率感觉都不高，这几句话完全要不到这么久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓医生的株式会社, createdTime=Thu Feb 08 14:17:06 CST 2024, time=2024-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2114002, encodeId=2d68211400214, content=审稿速度:2.0 偏重的研究方向：分子免疫;Hepatology;肝病 经验分享：大家好！一审大修under review后状态变成awaiting AE recommendation（等了5天左右），再变成awaiting EIC decision（1天），很快变成awaiting ME final processing（已经3天了），感觉最后一个状态很诡异，大家有类似的经历吗？欢迎沟通交流，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:27:55 CST 2023, time=2023-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125059, encodeId=f55e2125059ae, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=948b8628951, createdName=ms4000000661720880, createdTime=Tue Apr 11 11:52:12 CST 2023, time=2023-04-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116350, encodeId=e1bd21163504a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肝癌 经验分享：请问从接收到online大概要多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b05568141, createdName=ms4000000124404294, createdTime=Fri Feb 24 21:37:10 CST 2023, time=2023-02-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098040, encodeId=1a99209804099, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌 经验分享：6月底投稿，8月初返回大修，3周后重新提交，9月又返回小修，重新提交1个月后最终接收。审稿人意见友好，没有要求稿件的润色证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97be6539292, createdName=ms2000000353363357, createdTime=Wed Nov 02 13:06:31 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114003, encodeId=bcfa2114003dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：awaiting EIC decision后变成awaiting ME final processing是什么意思啊？已经几天了，编辑部处理速度好慢啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:32:58 CST 2023, time=2023-02-10, status=1, ipAttribution=)]

2024-05-06 ms3000001241002779 来自天津

审稿速度:2.0
偏重的研究方向：肝病
经验分享：提的意见超级无语…水平太差了吧再也不会投这个杂志避雷吧大家

43 0

[GetPortalCommentsPageByObjectIdResponse(id=2178018, encodeId=b85c21e8018b1, content=请问这个杂志under review就是送外审的意思呢？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri Dec 29 16:43:46 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201991, encodeId=d37e2201991f0, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：提的意见超级无语…水平太差了吧再也不会投这个杂志避雷吧大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d429198215, createdName=ms3000001241002779, createdTime=Mon May 06 12:32:06 CST 2024, time=2024-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2175943, encodeId=986b21e5943a9, content=一直是Awaiting AE First Review的状态不动啊？这是在等什么？外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e039032591, createdName=ms6000000888650478, createdTime=Tue Dec 19 18:16:06 CST 2023, time=2023-12-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1074977, encodeId=838810e497790, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：主编水平确实值得商榷！审稿人建议修改，而且都是小问题，但被主编直接拒绝，给出个可笑的理由---没有创新性！难道这个问题在决定送审前没有评估么？白白浪费几个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f07d2046503, createdName=edsv, createdTime=Mon Nov 29 09:15:09 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186526, encodeId=b01c2186526e8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：AE手里卡了一个月，审稿两个月，两个审稿人给了几句话的没啥建设性的评论，最后以“没有创新性”为理由拒了。编辑部和审稿人效率感觉都不高，这几句话完全要不到这么久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓医生的株式会社, createdTime=Thu Feb 08 14:17:06 CST 2024, time=2024-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2114002, encodeId=2d68211400214, content=审稿速度:2.0 偏重的研究方向：分子免疫;Hepatology;肝病 经验分享：大家好！一审大修under review后状态变成awaiting AE recommendation（等了5天左右），再变成awaiting EIC decision（1天），很快变成awaiting ME final processing（已经3天了），感觉最后一个状态很诡异，大家有类似的经历吗？欢迎沟通交流，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:27:55 CST 2023, time=2023-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125059, encodeId=f55e2125059ae, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=948b8628951, createdName=ms4000000661720880, createdTime=Tue Apr 11 11:52:12 CST 2023, time=2023-04-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116350, encodeId=e1bd21163504a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肝癌 经验分享：请问从接收到online大概要多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b05568141, createdName=ms4000000124404294, createdTime=Fri Feb 24 21:37:10 CST 2023, time=2023-02-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098040, encodeId=1a99209804099, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌 经验分享：6月底投稿，8月初返回大修，3周后重新提交，9月又返回小修，重新提交1个月后最终接收。审稿人意见友好，没有要求稿件的润色证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97be6539292, createdName=ms2000000353363357, createdTime=Wed Nov 02 13:06:31 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114003, encodeId=bcfa2114003dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：awaiting EIC decision后变成awaiting ME final processing是什么意思啊？已经几天了，编辑部处理速度好慢啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:32:58 CST 2023, time=2023-02-10, status=1, ipAttribution=)]

2023-12-19 ms6000000888650478 来自四川省

一直是Awaiting AE First Review的状态不动啊？这是在等什么？外审了吗？

57 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178018, encodeId=b85c21e8018b1, content=请问这个杂志under review就是送外审的意思呢？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri Dec 29 16:43:46 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201991, encodeId=d37e2201991f0, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：提的意见超级无语…水平太差了吧再也不会投这个杂志避雷吧大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d429198215, createdName=ms3000001241002779, createdTime=Mon May 06 12:32:06 CST 2024, time=2024-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2175943, encodeId=986b21e5943a9, content=一直是Awaiting AE First Review的状态不动啊？这是在等什么？外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e039032591, createdName=ms6000000888650478, createdTime=Tue Dec 19 18:16:06 CST 2023, time=2023-12-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1074977, encodeId=838810e497790, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：主编水平确实值得商榷！审稿人建议修改，而且都是小问题，但被主编直接拒绝，给出个可笑的理由---没有创新性！难道这个问题在决定送审前没有评估么？白白浪费几个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f07d2046503, createdName=edsv, createdTime=Mon Nov 29 09:15:09 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186526, encodeId=b01c2186526e8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：AE手里卡了一个月，审稿两个月，两个审稿人给了几句话的没啥建设性的评论，最后以“没有创新性”为理由拒了。编辑部和审稿人效率感觉都不高，这几句话完全要不到这么久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓医生的株式会社, createdTime=Thu Feb 08 14:17:06 CST 2024, time=2024-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2114002, encodeId=2d68211400214, content=审稿速度:2.0 偏重的研究方向：分子免疫;Hepatology;肝病 经验分享：大家好！一审大修under review后状态变成awaiting AE recommendation（等了5天左右），再变成awaiting EIC decision（1天），很快变成awaiting ME final processing（已经3天了），感觉最后一个状态很诡异，大家有类似的经历吗？欢迎沟通交流，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:27:55 CST 2023, time=2023-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125059, encodeId=f55e2125059ae, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=948b8628951, createdName=ms4000000661720880, createdTime=Tue Apr 11 11:52:12 CST 2023, time=2023-04-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116350, encodeId=e1bd21163504a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肝癌 经验分享：请问从接收到online大概要多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b05568141, createdName=ms4000000124404294, createdTime=Fri Feb 24 21:37:10 CST 2023, time=2023-02-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098040, encodeId=1a99209804099, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌 经验分享：6月底投稿，8月初返回大修，3周后重新提交，9月又返回小修，重新提交1个月后最终接收。审稿人意见友好，没有要求稿件的润色证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97be6539292, createdName=ms2000000353363357, createdTime=Wed Nov 02 13:06:31 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114003, encodeId=bcfa2114003dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：awaiting EIC decision后变成awaiting ME final processing是什么意思啊？已经几天了，编辑部处理速度好慢啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:32:58 CST 2023, time=2023-02-10, status=1, ipAttribution=)]

2021-11-29 edsv

审稿速度:2.0
偏重的研究方向：肝病
经验分享：主编水平确实值得商榷！审稿人建议修改，而且都是小问题，但被主编直接拒绝，给出个可笑的理由---没有创新性！难道这个问题在决定送审前没有评估么？白白浪费几个月的时间。

165 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178018, encodeId=b85c21e8018b1, content=请问这个杂志under review就是送外审的意思呢？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri Dec 29 16:43:46 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201991, encodeId=d37e2201991f0, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：提的意见超级无语…水平太差了吧再也不会投这个杂志避雷吧大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d429198215, createdName=ms3000001241002779, createdTime=Mon May 06 12:32:06 CST 2024, time=2024-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2175943, encodeId=986b21e5943a9, content=一直是Awaiting AE First Review的状态不动啊？这是在等什么？外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e039032591, createdName=ms6000000888650478, createdTime=Tue Dec 19 18:16:06 CST 2023, time=2023-12-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1074977, encodeId=838810e497790, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：主编水平确实值得商榷！审稿人建议修改，而且都是小问题，但被主编直接拒绝，给出个可笑的理由---没有创新性！难道这个问题在决定送审前没有评估么？白白浪费几个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f07d2046503, createdName=edsv, createdTime=Mon Nov 29 09:15:09 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186526, encodeId=b01c2186526e8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：AE手里卡了一个月，审稿两个月，两个审稿人给了几句话的没啥建设性的评论，最后以“没有创新性”为理由拒了。编辑部和审稿人效率感觉都不高，这几句话完全要不到这么久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓医生的株式会社, createdTime=Thu Feb 08 14:17:06 CST 2024, time=2024-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2114002, encodeId=2d68211400214, content=审稿速度:2.0 偏重的研究方向：分子免疫;Hepatology;肝病 经验分享：大家好！一审大修under review后状态变成awaiting AE recommendation（等了5天左右），再变成awaiting EIC decision（1天），很快变成awaiting ME final processing（已经3天了），感觉最后一个状态很诡异，大家有类似的经历吗？欢迎沟通交流，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:27:55 CST 2023, time=2023-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125059, encodeId=f55e2125059ae, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=948b8628951, createdName=ms4000000661720880, createdTime=Tue Apr 11 11:52:12 CST 2023, time=2023-04-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116350, encodeId=e1bd21163504a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肝癌 经验分享：请问从接收到online大概要多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b05568141, createdName=ms4000000124404294, createdTime=Fri Feb 24 21:37:10 CST 2023, time=2023-02-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098040, encodeId=1a99209804099, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌 经验分享：6月底投稿，8月初返回大修，3周后重新提交，9月又返回小修，重新提交1个月后最终接收。审稿人意见友好，没有要求稿件的润色证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97be6539292, createdName=ms2000000353363357, createdTime=Wed Nov 02 13:06:31 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114003, encodeId=bcfa2114003dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：awaiting EIC decision后变成awaiting ME final processing是什么意思啊？已经几天了，编辑部处理速度好慢啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:32:58 CST 2023, time=2023-02-10, status=1, ipAttribution=)]

2024-02-08 邓医生的株式会社来自安徽省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：AE手里卡了一个月，审稿两个月，两个审稿人给了几句话的没啥建设性的评论，最后以“没有创新性”为理由拒了。编辑部和审稿人效率感觉都不高，这几句话完全要不到这么久。

56 0

[GetPortalCommentsPageByObjectIdResponse(id=2178018, encodeId=b85c21e8018b1, content=请问这个杂志under review就是送外审的意思呢？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri Dec 29 16:43:46 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201991, encodeId=d37e2201991f0, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：提的意见超级无语…水平太差了吧再也不会投这个杂志避雷吧大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d429198215, createdName=ms3000001241002779, createdTime=Mon May 06 12:32:06 CST 2024, time=2024-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2175943, encodeId=986b21e5943a9, content=一直是Awaiting AE First Review的状态不动啊？这是在等什么？外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e039032591, createdName=ms6000000888650478, createdTime=Tue Dec 19 18:16:06 CST 2023, time=2023-12-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1074977, encodeId=838810e497790, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：主编水平确实值得商榷！审稿人建议修改，而且都是小问题，但被主编直接拒绝，给出个可笑的理由---没有创新性！难道这个问题在决定送审前没有评估么？白白浪费几个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f07d2046503, createdName=edsv, createdTime=Mon Nov 29 09:15:09 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186526, encodeId=b01c2186526e8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：AE手里卡了一个月，审稿两个月，两个审稿人给了几句话的没啥建设性的评论，最后以“没有创新性”为理由拒了。编辑部和审稿人效率感觉都不高，这几句话完全要不到这么久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓医生的株式会社, createdTime=Thu Feb 08 14:17:06 CST 2024, time=2024-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2114002, encodeId=2d68211400214, content=审稿速度:2.0 偏重的研究方向：分子免疫;Hepatology;肝病 经验分享：大家好！一审大修under review后状态变成awaiting AE recommendation（等了5天左右），再变成awaiting EIC decision（1天），很快变成awaiting ME final processing（已经3天了），感觉最后一个状态很诡异，大家有类似的经历吗？欢迎沟通交流，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:27:55 CST 2023, time=2023-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125059, encodeId=f55e2125059ae, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=948b8628951, createdName=ms4000000661720880, createdTime=Tue Apr 11 11:52:12 CST 2023, time=2023-04-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116350, encodeId=e1bd21163504a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肝癌 经验分享：请问从接收到online大概要多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b05568141, createdName=ms4000000124404294, createdTime=Fri Feb 24 21:37:10 CST 2023, time=2023-02-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098040, encodeId=1a99209804099, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌 经验分享：6月底投稿，8月初返回大修，3周后重新提交，9月又返回小修，重新提交1个月后最终接收。审稿人意见友好，没有要求稿件的润色证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97be6539292, createdName=ms2000000353363357, createdTime=Wed Nov 02 13:06:31 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114003, encodeId=bcfa2114003dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：awaiting EIC decision后变成awaiting ME final processing是什么意思啊？已经几天了，编辑部处理速度好慢啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:32:58 CST 2023, time=2023-02-10, status=1, ipAttribution=)]

2023-02-10 ms9000000740183862

审稿速度:2.0
偏重的研究方向：分子免疫;Hepatology;肝病
经验分享：大家好！一审大修under review后状态变成awaiting AE recommendation（等了5天左右），再变成awaiting EIC decision（1天），很快变成awaiting ME final processing（已经3天了），感觉最后一个状态很诡异，大家有类似的经历吗？欢迎沟通交流，谢谢！

75 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178018, encodeId=b85c21e8018b1, content=请问这个杂志under review就是送外审的意思呢？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri Dec 29 16:43:46 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201991, encodeId=d37e2201991f0, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：提的意见超级无语…水平太差了吧再也不会投这个杂志避雷吧大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d429198215, createdName=ms3000001241002779, createdTime=Mon May 06 12:32:06 CST 2024, time=2024-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2175943, encodeId=986b21e5943a9, content=一直是Awaiting AE First Review的状态不动啊？这是在等什么？外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e039032591, createdName=ms6000000888650478, createdTime=Tue Dec 19 18:16:06 CST 2023, time=2023-12-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1074977, encodeId=838810e497790, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：主编水平确实值得商榷！审稿人建议修改，而且都是小问题，但被主编直接拒绝，给出个可笑的理由---没有创新性！难道这个问题在决定送审前没有评估么？白白浪费几个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f07d2046503, createdName=edsv, createdTime=Mon Nov 29 09:15:09 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186526, encodeId=b01c2186526e8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：AE手里卡了一个月，审稿两个月，两个审稿人给了几句话的没啥建设性的评论，最后以“没有创新性”为理由拒了。编辑部和审稿人效率感觉都不高，这几句话完全要不到这么久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓医生的株式会社, createdTime=Thu Feb 08 14:17:06 CST 2024, time=2024-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2114002, encodeId=2d68211400214, content=审稿速度:2.0 偏重的研究方向：分子免疫;Hepatology;肝病 经验分享：大家好！一审大修under review后状态变成awaiting AE recommendation（等了5天左右），再变成awaiting EIC decision（1天），很快变成awaiting ME final processing（已经3天了），感觉最后一个状态很诡异，大家有类似的经历吗？欢迎沟通交流，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:27:55 CST 2023, time=2023-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125059, encodeId=f55e2125059ae, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=948b8628951, createdName=ms4000000661720880, createdTime=Tue Apr 11 11:52:12 CST 2023, time=2023-04-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116350, encodeId=e1bd21163504a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肝癌 经验分享：请问从接收到online大概要多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b05568141, createdName=ms4000000124404294, createdTime=Fri Feb 24 21:37:10 CST 2023, time=2023-02-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098040, encodeId=1a99209804099, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌 经验分享：6月底投稿，8月初返回大修，3周后重新提交，9月又返回小修，重新提交1个月后最终接收。审稿人意见友好，没有要求稿件的润色证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97be6539292, createdName=ms2000000353363357, createdTime=Wed Nov 02 13:06:31 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114003, encodeId=bcfa2114003dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：awaiting EIC decision后变成awaiting ME final processing是什么意思啊？已经几天了，编辑部处理速度好慢啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:32:58 CST 2023, time=2023-02-10, status=1, ipAttribution=)]

2023-04-11 ms4000000661720880 来自上海

1

58 0

[GetPortalCommentsPageByObjectIdResponse(id=2178018, encodeId=b85c21e8018b1, content=请问这个杂志under review就是送外审的意思呢？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri Dec 29 16:43:46 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201991, encodeId=d37e2201991f0, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：提的意见超级无语…水平太差了吧再也不会投这个杂志避雷吧大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d429198215, createdName=ms3000001241002779, createdTime=Mon May 06 12:32:06 CST 2024, time=2024-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2175943, encodeId=986b21e5943a9, content=一直是Awaiting AE First Review的状态不动啊？这是在等什么？外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e039032591, createdName=ms6000000888650478, createdTime=Tue Dec 19 18:16:06 CST 2023, time=2023-12-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1074977, encodeId=838810e497790, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：主编水平确实值得商榷！审稿人建议修改，而且都是小问题，但被主编直接拒绝，给出个可笑的理由---没有创新性！难道这个问题在决定送审前没有评估么？白白浪费几个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f07d2046503, createdName=edsv, createdTime=Mon Nov 29 09:15:09 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186526, encodeId=b01c2186526e8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：AE手里卡了一个月，审稿两个月，两个审稿人给了几句话的没啥建设性的评论，最后以“没有创新性”为理由拒了。编辑部和审稿人效率感觉都不高，这几句话完全要不到这么久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓医生的株式会社, createdTime=Thu Feb 08 14:17:06 CST 2024, time=2024-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2114002, encodeId=2d68211400214, content=审稿速度:2.0 偏重的研究方向：分子免疫;Hepatology;肝病 经验分享：大家好！一审大修under review后状态变成awaiting AE recommendation（等了5天左右），再变成awaiting EIC decision（1天），很快变成awaiting ME final processing（已经3天了），感觉最后一个状态很诡异，大家有类似的经历吗？欢迎沟通交流，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:27:55 CST 2023, time=2023-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125059, encodeId=f55e2125059ae, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=948b8628951, createdName=ms4000000661720880, createdTime=Tue Apr 11 11:52:12 CST 2023, time=2023-04-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116350, encodeId=e1bd21163504a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肝癌 经验分享：请问从接收到online大概要多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b05568141, createdName=ms4000000124404294, createdTime=Fri Feb 24 21:37:10 CST 2023, time=2023-02-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098040, encodeId=1a99209804099, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌 经验分享：6月底投稿，8月初返回大修，3周后重新提交，9月又返回小修，重新提交1个月后最终接收。审稿人意见友好，没有要求稿件的润色证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97be6539292, createdName=ms2000000353363357, createdTime=Wed Nov 02 13:06:31 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114003, encodeId=bcfa2114003dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：awaiting EIC decision后变成awaiting ME final processing是什么意思啊？已经几天了，编辑部处理速度好慢啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:32:58 CST 2023, time=2023-02-10, status=1, ipAttribution=)]

2023-02-24 ms4000000124404294 来自江苏省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：肝癌
经验分享：请问从接收到online大概要多长时间啊

69 0

[GetPortalCommentsPageByObjectIdResponse(id=2178018, encodeId=b85c21e8018b1, content=请问这个杂志under review就是送外审的意思呢？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri Dec 29 16:43:46 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201991, encodeId=d37e2201991f0, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：提的意见超级无语…水平太差了吧再也不会投这个杂志避雷吧大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d429198215, createdName=ms3000001241002779, createdTime=Mon May 06 12:32:06 CST 2024, time=2024-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2175943, encodeId=986b21e5943a9, content=一直是Awaiting AE First Review的状态不动啊？这是在等什么？外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e039032591, createdName=ms6000000888650478, createdTime=Tue Dec 19 18:16:06 CST 2023, time=2023-12-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1074977, encodeId=838810e497790, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：主编水平确实值得商榷！审稿人建议修改，而且都是小问题，但被主编直接拒绝，给出个可笑的理由---没有创新性！难道这个问题在决定送审前没有评估么？白白浪费几个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f07d2046503, createdName=edsv, createdTime=Mon Nov 29 09:15:09 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186526, encodeId=b01c2186526e8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：AE手里卡了一个月，审稿两个月，两个审稿人给了几句话的没啥建设性的评论，最后以“没有创新性”为理由拒了。编辑部和审稿人效率感觉都不高，这几句话完全要不到这么久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓医生的株式会社, createdTime=Thu Feb 08 14:17:06 CST 2024, time=2024-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2114002, encodeId=2d68211400214, content=审稿速度:2.0 偏重的研究方向：分子免疫;Hepatology;肝病 经验分享：大家好！一审大修under review后状态变成awaiting AE recommendation（等了5天左右），再变成awaiting EIC decision（1天），很快变成awaiting ME final processing（已经3天了），感觉最后一个状态很诡异，大家有类似的经历吗？欢迎沟通交流，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:27:55 CST 2023, time=2023-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125059, encodeId=f55e2125059ae, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=948b8628951, createdName=ms4000000661720880, createdTime=Tue Apr 11 11:52:12 CST 2023, time=2023-04-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116350, encodeId=e1bd21163504a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肝癌 经验分享：请问从接收到online大概要多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b05568141, createdName=ms4000000124404294, createdTime=Fri Feb 24 21:37:10 CST 2023, time=2023-02-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098040, encodeId=1a99209804099, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌 经验分享：6月底投稿，8月初返回大修，3周后重新提交，9月又返回小修，重新提交1个月后最终接收。审稿人意见友好，没有要求稿件的润色证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97be6539292, createdName=ms2000000353363357, createdTime=Wed Nov 02 13:06:31 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114003, encodeId=bcfa2114003dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：awaiting EIC decision后变成awaiting ME final processing是什么意思啊？已经几天了，编辑部处理速度好慢啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:32:58 CST 2023, time=2023-02-10, status=1, ipAttribution=)]

2022-11-02 ms2000000353363357

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肝癌
经验分享：6月底投稿，8月初返回大修，3周后重新提交，9月又返回小修，重新提交1个月后最终接收。审稿人意见友好，没有要求稿件的润色证明。

89 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178018, encodeId=b85c21e8018b1, content=请问这个杂志under review就是送外审的意思呢？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri Dec 29 16:43:46 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201991, encodeId=d37e2201991f0, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：提的意见超级无语…水平太差了吧再也不会投这个杂志避雷吧大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d429198215, createdName=ms3000001241002779, createdTime=Mon May 06 12:32:06 CST 2024, time=2024-05-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2175943, encodeId=986b21e5943a9, content=一直是Awaiting AE First Review的状态不动啊？这是在等什么？外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e039032591, createdName=ms6000000888650478, createdTime=Tue Dec 19 18:16:06 CST 2023, time=2023-12-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1074977, encodeId=838810e497790, content=审稿速度:2.0 偏重的研究方向：肝病 经验分享：主编水平确实值得商榷！审稿人建议修改，而且都是小问题，但被主编直接拒绝，给出个可笑的理由---没有创新性！难道这个问题在决定送审前没有评估么？白白浪费几个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f07d2046503, createdName=edsv, createdTime=Mon Nov 29 09:15:09 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186526, encodeId=b01c2186526e8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：AE手里卡了一个月，审稿两个月，两个审稿人给了几句话的没啥建设性的评论，最后以“没有创新性”为理由拒了。编辑部和审稿人效率感觉都不高，这几句话完全要不到这么久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓医生的株式会社, createdTime=Thu Feb 08 14:17:06 CST 2024, time=2024-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2114002, encodeId=2d68211400214, content=审稿速度:2.0 偏重的研究方向：分子免疫;Hepatology;肝病 经验分享：大家好！一审大修under review后状态变成awaiting AE recommendation（等了5天左右），再变成awaiting EIC decision（1天），很快变成awaiting ME final processing（已经3天了），感觉最后一个状态很诡异，大家有类似的经历吗？欢迎沟通交流，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:27:55 CST 2023, time=2023-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125059, encodeId=f55e2125059ae, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=948b8628951, createdName=ms4000000661720880, createdTime=Tue Apr 11 11:52:12 CST 2023, time=2023-04-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116350, encodeId=e1bd21163504a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肝癌 经验分享：请问从接收到online大概要多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b05568141, createdName=ms4000000124404294, createdTime=Fri Feb 24 21:37:10 CST 2023, time=2023-02-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098040, encodeId=1a99209804099, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌 经验分享：6月底投稿，8月初返回大修，3周后重新提交，9月又返回小修，重新提交1个月后最终接收。审稿人意见友好，没有要求稿件的润色证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97be6539292, createdName=ms2000000353363357, createdTime=Wed Nov 02 13:06:31 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114003, encodeId=bcfa2114003dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：awaiting EIC decision后变成awaiting ME final processing是什么意思啊？已经几天了，编辑部处理速度好慢啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76a05380136, createdName=ms9000000740183862, createdTime=Fri Feb 10 18:32:58 CST 2023, time=2023-02-10, status=1, ipAttribution=)]

2023-02-10 ms9000000740183862

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肝病
经验分享：awaiting EIC decision后变成awaiting ME final processing是什么意思啊？已经几天了，编辑部处理速度好慢啊！

66 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务